Camurus AB (publ) (STO:CAMX)
Sweden · Delayed Price · Currency is SEK 547.50
+16.50 (3.11%)
May 4, 2026, 5:29 PM CET
Camurus AB Market Cap
Camurus AB has a market cap or net worth of 32.71 billion as of May 4, 2026. Its market cap has increased by 2.55% in one year.
Market Cap
32.71B
Enterprise Value
29.09B
Revenue
2.27B
Ranking
n/a
PE Ratio
44.66
Stock Price
547.50
Market Cap Chart
Since December 3, 2015, Camurus AB's market cap has increased from 1.66B to 32.71B, an increase of 1,866.18%. That is a compound annual growth rate of 33.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 32.71B | -10.96% |
| Dec 30, 2025 | 36.74B | 10.34% |
| Dec 30, 2024 | 33.30B | 11.26% |
| Dec 29, 2023 | 29.93B | 113.76% |
| Dec 30, 2022 | 14.00B | 69.32% |
| Dec 30, 2021 | 8.27B | -18.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioArctic AB | 28.73B |
| Vicore Pharma Holding AB | 2.81B |
| Hansa Biopharma AB | 2.77B |
| Flerie AB | 2.26B |
| Egetis Therapeutics AB | 2.22B |
| Saniona AB | 1.93B |
| BioInvent International AB | 1.44B |
| Genovis AB (publ.) | 1.28B |